Critical receptor involved in response to antidepressants like ketamine
Thursday, March 28, 2019 - 18:00
in Health & Medicine
Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.